← Leaderboards
Catherine M Kotz
University Of Minnesota Twin Cities
$5,980,367
Attributed
$9,173,176
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,173,176 · 5
VA$0 · 6
By mechanism
R01$5,419,499 · 4
T32$3,753,677 · 1
I01$0 · 5
IS1$0 · 1
Top collaborators
- Charles J. Billington13 shared
- Robert W Jeffery7 shared
- Melissa N. Laska6 shared
- Nancy E Sherwood6 shared
- Yanan Zhang3 shared
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Charles J. Billington$324,566
- Ladora V. Thompson$6,730,455
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityBrainPhysical ActivityHypocretinNeuronsAffectAnimalsReceptorHypothalamic StructureBody WeightOrexin AAreaMediatingPreventNeuropeptidesWeight GainObesity TreatmentVeteransAutomobile DrivingEatingRattusBaseResistanceChronic
Grant awards (54)
Reducing the post weight-loss energy expenditure gap with orexin agonists$672,884
R01 · FY2025 · DK · contact PI
Fisetin as a treatment for community-acquired pathogen susceptibility during aging, obesity and neurodegenerative diseases$0
I01 · FY2025 · VA · contact PI
Reducing the post weight-loss energy expenditure gap with orexin agonists$645,968
R01 · FY2024 · DK · contact PI
Minnesota Obesity Prevention Training (MnOPT)$427,863
T32 · FY2024 · DK · contact PI
Orexin agonists as novel obesity therapeutics$0
I01 · FY2024 · VA · contact PI
Fisetin as a treatment for community-acquired pathogen susceptibility during aging, obesity and neurodegenerative diseases$0
I01 · FY2024 · VA · contact PI
Reducing the post weight-loss energy expenditure gap with orexin agonists$731,008
R01 · FY2023 · DK · contact PI
Minnesota Obesity Prevention Training (MnOPT)$367,776
T32 · FY2023 · DK · contact PI
Orexin agonists as novel obesity therapeutics$0
I01 · FY2023 · VA · contact PI
Fisetin as a treatment for community-acquired pathogen susceptibility during aging, obesity and neurodegenerative diseases$0
I01 · FY2023 · VA · contact PI
Minnesota Obesity Prevention Training (MnOPT)$397,362
T32 · FY2022 · DK · contact PI
Minnesota Obesity Prevention Training (MnOPT)$87,620
T32 · FY2022 · DK · contact PI
Orexin and serotonin interactions to promote physical activity and prevent obesity$0
I01 · FY2022 · VA · contact PI
Fisetin as a treatment for community-acquired pathogen susceptibility during aging, obesity and neurodegenerative diseases$0
I01 · FY2022 · VA · contact PI
Orexin agonists as novel obesity therapeutics$0
I01 · FY2022 · VA · contact PI
Minnesota Obesity Prevention Training (MnOPT)$382,193
T32 · FY2021 · DK · contact PI
Minnesota Obesity Prevention Training (MnOPT)$83,431
T32 · FY2021 · DK · contact PI
Orexin and serotonin interactions to promote physical activity and prevent obesity$0
I01 · FY2021 · VA · contact PI
Minnesota Obesity Prevention Training (MnOPT)$246,510
T32 · FY2020 · DK · contact PI
Orexin and serotonin interactions to promote physical activity and prevent obesity$0
I01 · FY2020 · VA · contact PI
Minnesota Obesity Prevention Training (MnOPT)$398,711
T32 · FY2019 · DK · contact PI
Rescue of dormant brain circuits in neurodegenerative disease$0
I01 · FY2019 · VA · contact PI
Orexin and serotonin interactions to promote physical activity and prevent obesity$0
I01 · FY2019 · VA · contact PI
Minnesota Obesity Prevention Training (MnOPT)$376,977
T32 · FY2018 · DK
Rescue of dormant brain circuits in neurodegenerative disease$0
I01 · FY2018 · VA · contact PI
Orexin and serotonin interactions to promote physical activity and prevent obesity$0
I01 · FY2018 · VA · contact PI
Minnesota Obesity Prevention Training (MnOPT)$286,193
T32 · FY2017 · DK
Role of Variability in SPA in Susceptibility to Obesity$280,350
R01 · FY2017 · DK · contact PI
Minnesota Obesity Prevention Training (MnOPT)$4,592
T32 · FY2017 · DK
Rescue of dormant brain circuits in neurodegenerative disease$0
I01 · FY2017 · VA · contact PI
Minnesota Obesity Prevention Training (MnOPT)$330,186
T32 · FY2016 · DK
Role of Variability in SPA in Susceptibility to Obesity$280,350
R01 · FY2016 · DK · contact PI
Rescue of dormant brain circuits in neurodegenerative disease$0
I01 · FY2016 · VA · contact PI
ShEEP Request for Acquisition of Sable Promethion Caging$0
IS1 · FY2016 · VA · contact PI
Minnesota Obesity Prevention Training (MnOPT)$364,263
T32 · FY2015 · DK
Role of Variability in SPA in Susceptibility to Obesity$280,350
R01 · FY2015 · DK · contact PI
Enhancing NEAT to Treat Obesity$0
I01 · FY2015 · VA · contact PI
Role of Variability in SPA in Susceptibility to Obesity$280,350
R01 · FY2014 · DK · contact PI
Enhancing NEAT to Treat Obesity$0
I01 · FY2014 · VA · contact PI
Enhancing NEAT to Treat Obesity$0
I01 · FY2014 · VA · contact PI
Spontaneous Physical Activity in Obesity$265,778
R01 · FY2012 · DK · contact PI
Enhancing NEAT to Treat Obesity$0
I01 · FY2012 · VA · contact PI
Spontaneous physical activity in obesity$331,115
R01 · FY2011 · DK · contact PI
Spontaneous physical activity in obesity$293,040
R01 · FY2010 · DK · contact PI
Spontaneous physical activity in obesity$67,124
R01 · FY2010 · DK · contact PI
Spontaneous physical activity in obesity$295,797
R01 · FY2009 · DK · contact PI
Spontaneous physical activity in obesity$31,046
R01 · FY2009 · DK · contact PI
HYPOTHALAMIC HYPOCRETIN PATHWAYS MODULATING FEEDING$189,000
R01 · FY2004 · DK
HYPOTHALAMIC HYPOCRETIN PATHWAYS MODULATING FEEDING$183,993
R01 · FY2003 · DK
HYPOTHALAMIC HYPOCRETIN PATHWAYS MODULATING FEEDING$32,130
R01 · FY2003 · DK
HYPOTHALAMIC HYPOCRETIN PATHWAYS MODULATING FEEDING$178,633
R01 · FY2002 · DK
HYPOTHALAMIC HYPOCRETIN PATHWAYS MODULATING FEEDING$173,174
R01 · FY2001 · DK
HYPOTHALAMIC HYPOCRETIN PATHWAYS MODULATING FEEDING$31,555
R01 · FY2001 · DK
HYPOTHALAMIC HYPOCRETIN PATHWAYS MODULATING FEEDING$175,854
R01 · FY2000 · DK